Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 2
1999 1
2000 1
2001 2
2002 5
2003 3
2005 1
2006 3
2008 4
2009 1
2011 3
2012 2
2015 1
2017 3
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Integrity testing.
Jornitz MW. Jornitz MW. Adv Biochem Eng Biotechnol. 2006;98:143-80. doi: 10.1007/b104248. Adv Biochem Eng Biotechnol. 2006. PMID: 16570865 Review.
Membrane filtration.
Brose DJ, Dosmar M, Jornitz MW. Brose DJ, et al. Among authors: jornitz mw. Pharm Biotechnol. 2002;14:213-79. doi: 10.1007/978-1-4615-0549-5_5. Pharm Biotechnol. 2002. PMID: 12189726 Review. No abstract available.
Types of filtration.
Levy RV, Jornitz MW. Levy RV, et al. Among authors: jornitz mw. Adv Biochem Eng Biotechnol. 2006;98:1-26. doi: 10.1007/b104242. Adv Biochem Eng Biotechnol. 2006. PMID: 16570860 Review.
Filter construction and design.
Jornitz MW. Jornitz MW. Adv Biochem Eng Biotechnol. 2006;98:105-23. doi: 10.1007/b104244. Adv Biochem Eng Biotechnol. 2006. PMID: 16570863 Review.
Membrane separations.
Walter JK, Jin Z, Jornitz MW, Gorrschalk U. Walter JK, et al. Among authors: jornitz mw. Methods Biochem Anal. 2011;54:281-317. Methods Biochem Anal. 2011. PMID: 21954783 Review. No abstract available.
PDA Points to Consider: Technical Product Lifecycle Management. Pharmaceutical Quality System Effectiveness for Managing Post-approval Changes.
Authors: Members of the PDA Task Force on Post-approval Changes for Innovation in Availability of Medicines (PAC iAMsm), Ramnarine E, Busse U, Colao M, Edwards J, O'Donnell K, Jornitz M, Munk M, Seymour M, Simianu M, Skeens L, Vinther A. Authors: Members of the PDA Task Force on Post-approval Changes for Innovation in Availability of Medicines (PAC iAMsm), et al. Among authors: jornitz m. PDA J Pharm Sci Technol. 2017 May-Jun;71(3):252-258. doi: 10.5731/pdajpst.2017.007575. Epub 2017 Feb 14. PDA J Pharm Sci Technol. 2017. PMID: 28196929 Review. No abstract available.
PDA Points To Consider: Technical Product Lifecycle Management: Communication and Knowledge Exchange between Marketing Authorization Holders and Health Authorities.
Authors: Members of the PDA Task Force Post Approval Changes for Innovation in Availability of Medicines (PAC iAM), Ramnarine E, Busse U, Colao M, Edwards J, Jornitz M, Munk M, Seymour M, Simianu M, Skeens L, Vinther A. Authors: Members of the PDA Task Force Post Approval Changes for Innovation in Availability of Medicines (PAC iAM), et al. Among authors: jornitz m. PDA J Pharm Sci Technol. 2017 Mar-Apr;71(2):163-169. doi: 10.5731/pdajpst.2016.007492. Epub 2017 Jan 15. PDA J Pharm Sci Technol. 2017. PMID: 28089963 Review. No abstract available.
34 results